Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups.


Journal

Clinical chemistry and laboratory medicine
ISSN: 1437-4331
Titre abrégé: Clin Chem Lab Med
Pays: Germany
ID NLM: 9806306

Informations de publication

Date de publication:
27 07 2021
Historique:
received: 08 02 2021
accepted: 29 03 2021
pubmed: 7 4 2021
medline: 8 7 2021
entrez: 6 4 2021
Statut: epublish

Résumé

Compared to RT-PCR, lower performance of antigen detection assays, including the Lumipulse G SARS-CoV-2 Ag assay, may depend on specific testing scenarios. We tested 594 nasopharyngeal swab samples from individuals with COVID-19 (RT-PCR cycle threshold [Ct] values ≤ 40) or non-COVID-19 (Ct values >40) diagnoses. RT-PCR positive samples were assigned to diagnostic, screening, or monitoring groups of testing. With a limit of detection of 1.2 × 10 Lumipulse assay was highly sensitive in samples with low RT-PCR Ct values, implying repeated testing to reduce consequences of false-negative results.

Identifiants

pubmed: 33823089
pii: cclm-2021-0182
doi: 10.1515/cclm-2021-0182
doi:

Substances chimiques

RNA, Viral 0
Reagent Kits, Diagnostic 0

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1468-1476

Informations de copyright

© 2021 Giulia Menchinelli et al., published by De Gruyter, Berlin/Boston.

Références

Brooks, ZC, Das, S. COVID-19 testing. Am J Clin Pathol 2020;154:575–84. https://doi.org/10.1093/ajcp/aqaa141.
Cheng, MP, Papenburg, J, Desjardins, M, Kanjilal, S, Quach, C, Libman, M, et al.. Diagnostic testing for severe acute respiratory syndrome–related coronavirus-2: a narrative review. Ann Intern Med 2020:M20–1301.
Mak, GC, Lau, SS, Wong, KK, Chow, NL, Lau, CS, Lam, ET, et al.. Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus. J Clin Virol 2020;133:104684. https://doi.org/10.1016/j.jcv.2020.104684.
Ogawa, T, Fukumori, T, Nishihara, Y, Sekine, T, Okuda, N, Nishimura, T, et al.. Another false-positive problem for a SARS-CoV-2 antigen test in Japan. J Clin Virol 2020;131:104612. https://doi.org/10.1016/j.jcv.2020.104612.
European Centre for Disease Prevention and Control (ECDC). Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK. 19 November 2020. Stockholm: ECDC; 2020.
Hirotsu, Y, Maejima, M, Shibusawa, M, Nagakubo, Y, Hosaka, K, Amemiya, K, et al.. Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients. Int J Infect Dis 2020;99:397–402. https://doi.org/10.1016/j.ijid.2020.08.029.
Hirotsu, Y, Maejima, M, Shibusawa, M, Amemiya, K, Nagakubo, Y, Hosaka, K, et al.. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection. J Infect Chemother 2021;27:406–9. https://doi.org/10.1016/j.jiac.2020.10.026.
Hirotsu, Y, Maejima, M, Shibusawa, M, Amemiya, K, Nagakubo, Y, Hosaka, K, et al.. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: comparison with RT-qPCR. Int J Infect Dis 2021;105:7–14. https://doi.org/10.1016/j.ijid.2021.02.005.
Basso, D, Aita, A, Padoan, A, Cosma, C, Navaglia, F, Moz, S, et al.. Salivary SARS-CoV-2 antigen rapid detection: a prospective cohort study. Clin Chim Acta 2021;517:54–9. https://doi.org/10.1016/j.cca.2021.02.014.
Wölfel, R, Corman, VM, Guggemos, W, Seilmaier, M, Zange, S, Müller, MA, et al.. Virological assessment of hospitalized patients with COVID-2019. Nature 2020;581:465–9. https://doi.org/10.1038/s41586-020-2196-x.
Liotti, FM, Menchinelli, G, Marchetti, S, Morandotti, GA, Sanguinetti, M, Posteraro, B, et al.. Evaluation of three commercial assays for SARS-CoV-2 molecular detection in upper respiratory tract samples. Eur J Clin Microbiol Infect Dis 2021;40:269–77. https://doi.org/10.1007/s10096-020-04025-0.
Liotti, FM, Menchinelli, G, Lalle, E, Palucci, I, Marchetti, S, Colavita, F, et al.. Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples. Clin Microbiol Infect 2021;27:487–8. https://doi.org/10.1016/j.cmi.2020.09.030.
Poljak, M, Korva, M, Knap Gašper, N, Fujs Komloš, K, Sagadin, M, Uršič, T, et al.. Clinical evaluation of the Cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic. J Clin Microbiol 2020;58:e00599–20. https://doi.org/10.1128/jcm.00599-20.
Procop, GW, Brock, JE, Reineks, EZ, Shrestha, NK, Demkowicz, R, Cook, E, et al.. Comparison of five SARS-CoV-2 molecular assays with clinical correlations. Am J Clin Pathol 2021;155:69–78. https://doi.org/10.1093/ajcp/aqaa181.
Liotti, FM, Menchinelli, G, Marchetti, S, Morandotti, GA, Sanguinetti, M, Posteraro, B, et al.. Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection. Clin Microbiol Infect 2020;26:1699–700. https://doi.org/10.1016/j.cmi.2020.07.026.
Liotti, FM, Menchinelli, G, Marchetti, S, Posteraro, B, Landi, F, Sanguinetti, M, et al.. Assessment of SARS-CoV-2 RNA test results among patients who recovered from COVID-19 with prior negative results. JAMA Intern Med 2020:e207570. https://doi.org/10.1001/jamainternmed.2020.7570.
Alexandersen, S, Chamings, A, Bhatta, TR. SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication. Nat Commun 2020;11:6059. https://doi.org/10.1038/s41467-020-19883-7.
Rodríguez-Grande, C, Adán-Jiménez, J, Catalán, P, Alcalá, L, Estévez, A, Muñoz, P, et al.. Inference of active viral replication in cases with sustained positive RT-PCRs for SARS-CoV-2. J Clin Microbiol 2021;59:e02277–20. https://doi.org/10.1128/jcm.02277-20.
Avanzato, VA, Matson, MJ, Seifert, SN, Pryce, R, Williamson, BN, Anzick, SL, et al.. Case Study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell 2020;183:1901–12. https://doi.org/10.1016/j.cell.2020.10.049.
van Kampen JJA, van de Vijver, DAMC, Fraaij, PLA, Haagmans, BL, Lamers, MM, Okba, N, et al.. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun 2021;12:267. https://doi.org/10.1038/s41467-020-20568-4.
Dinnes, J, Deeks, JJ, Adriano, A, Berhane, S, Davenport, C, Dittrich, S, et al.. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev 2020;8:CD013705. https://doi.org/10.1002/14651858.cd013705.

Auteurs

Giulia Menchinelli (G)

Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Licia Bordi (L)

Istituto Nazionale per le Malattie Infettive (INMI) Lazzaro Spallanzani IRCCS, Rome, Italy.

Flora Marzia Liotti (FM)

Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Ivana Palucci (I)

Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Maria Rosaria Capobianchi (MR)

Istituto Nazionale per le Malattie Infettive (INMI) Lazzaro Spallanzani IRCCS, Rome, Italy.

Giuseppe Sberna (G)

Istituto Nazionale per le Malattie Infettive (INMI) Lazzaro Spallanzani IRCCS, Rome, Italy.

Eleonora Lalle (E)

Istituto Nazionale per le Malattie Infettive (INMI) Lazzaro Spallanzani IRCCS, Rome, Italy.

Lucio Romano (L)

Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Giulia De Angelis (G)

Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Simona Marchetti (S)

Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Maurizio Sanguinetti (M)

Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Paola Cattani (P)

Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Brunella Posteraro (B)

Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH